SCHEMBL22423998

SCHEMBL22423998

O=C(c1ccc(Cl)c(Cl)c1)N1CCc2c(nc(NCc3ccccc3)[nH]c2=O)C1

nearest known ligand 0.60

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
▸ CLPP Q16740 17/20 0.60
▸ HPGD P15428 1/20 0.53
▸ PKM P14618 1/20 0.53
▸ L3MBTL1 Q9Y468 1/20 0.53
▸ MTHFD2 P13995 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22424333 0.89 CLPP (0.54) CLPPHPGD
SCHEMBL22424550 0.82 CLPP (0.53) CLPPHPGD
SCHEMBL22424217 0.82 CLPP (0.52) CLPPHPGD
SCHEMBL22424585 0.82 CLPP (0.52) CLPP
SCHEMBL22424705 0.82 MTHFD2 (0.45) CLPPHPGDPKMMTHFD2
SCHEMBL22424334 0.81 HPGD (0.46) CLPPHPGDPKMMTHFD2
SCHEMBL22423997 0.81 PRLHR (0.47) CLPPMTHFD2
SCHEMBL22424574 0.81 CLPP (0.51) CLPP
SCHEMBL22424384 0.81 CLPP (0.51) CLPP
SCHEMBL22424053 0.81 MTHFD2 (0.52) HPGDPKMMTHFD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020182990-A1 FUSED RING PYRIMIDONE DERIVATIVES FOR USE IN THE TREATMENT OF HBV INFECTION OR OF HBV-INDUCED DISEASES Janssen Sciences Ireland Unlimited Company (IE) 2020-09-17 — — WO disclosed
Send feedback